139 related articles for article (PubMed ID: 17627572)
1. Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi RK; Katti SB; Pannecouque C; De Clercq E
Med Chem; 2007 Jul; 3(4):355-63. PubMed ID: 17627572
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
3. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents.
Rawal RK; Tripathi R; Kulkarni S; Paranjape R; Katti SB; Pannecouque C; De Clercq E
Chem Biol Drug Des; 2008 Aug; 72(2):147-54. PubMed ID: 18624810
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 Feb; 15(4):1725-31. PubMed ID: 17178227
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling studies of new 2,3-diheteroaryl thiazolidin-4-ones as NNRTIs.
Debnath U; Verma S; Singh P; Rawat K; Gupta SK; Tripathi RK; Siddiqui HH; Katti SB; Prabhakar YS
Chem Biol Drug Des; 2015 Nov; 86(5):1285-91. PubMed ID: 26031778
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Farmaco; 2004 Jan; 59(1):33-9. PubMed ID: 14751314
[TBL] [Abstract][Full Text] [Related]
8. Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones.
Chen H; Bai J; Jiao L; Guo Z; Yin Q; Li X
Bioorg Med Chem; 2009 Jun; 17(11):3980-6. PubMed ID: 19411176
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones.
Balzarini J; Orzeszko-Krzesińska B; Maurin JK; Orzeszko A
Eur J Med Chem; 2009 Jan; 44(1):303-11. PubMed ID: 18420310
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of new substituted methyl [2-(arylmethylene-hydrazino)-4-oxo-thiazolidin-5-ylidene]acetates.
Saeed A; Al-Masoudi NA; Latif M
Arch Pharm (Weinheim); 2013 Aug; 346(8):618-25. PubMed ID: 23828482
[TBL] [Abstract][Full Text] [Related]
11. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones.
Balzarini J; Orzeszko B; Maurin JK; Orzeszko A
Eur J Med Chem; 2007 Jul; 42(7):993-1003. PubMed ID: 17321639
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones.
Rao A; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Farmaco; 2003 Feb; 58(2):115-20. PubMed ID: 12581777
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.
Barreca ML; Chimirri A; De Luca L; Monforte AM; Monforte P; Rao A; Zappalà M; Balzarini J; De Clercq E; Pannecouque C; Witvrouw M
Bioorg Med Chem Lett; 2001 Jul; 11(13):1793-6. PubMed ID: 11425562
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
[TBL] [Abstract][Full Text] [Related]
16. 1H-Tetrazol-5-amine and 1,3-thiazolidin-4-one derivatives containing 3-(trifluoromethyl)phenyl scaffold: Synthesis, cytotoxic and anti-HIV studies.
Bielenica A; Szulczyk D; Olejarz W; Madeddu S; Giliberti G; Materek IB; Koziol AE; Struga M
Biomed Pharmacother; 2017 Oct; 94():804-812. PubMed ID: 28802233
[TBL] [Abstract][Full Text] [Related]
17. Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Murugesan V; Makwana N; Suryawanshi R; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Katti SB
Bioorg Med Chem; 2014 Jun; 22(12):3159-70. PubMed ID: 24794742
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazoles Part 6. Synthesis, structure and in vitro anti-HIV activity of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Masoudi NA; Al-Soud YA; De Clercq E; Pannecouque C
Antivir Chem Chemother; 2007; 18(4):191-200. PubMed ID: 17907377
[TBL] [Abstract][Full Text] [Related]
19. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
Rawal RK; Prabhakar YS; Katti SB; De Clercq E
Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the research of 2,3-diaryl-1,3-thiazolidin-4-one derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Tian Y; Zhan P; Rai D; Zhang J; De Clercq E; Liu X
Curr Med Chem; 2012; 19(13):2026-37. PubMed ID: 22429098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
